Page 316 - Drug Class Review
P. 316
Page 188 of 205
Drug Effectiveness Review Project
To conduct a pharmacodynamic analysis of potential drug interactions between RIV and other
Country: NR (authors from Switzerland and the US; trials not reported in detail)
placebo N/A 6 months 763
Drugs Authors: Grossberg et al. 92 medications commonly prescribed in the elderly AD population Study design: Post-hoc analysis of data from 4 RCTs rivastigmine 1 to 12 mg/d 6 months 1,696 Patients randomized in placebo-controlled trials of RIV
Alzheimer Year: 2000 Novartis Setting: NR Sample size: 2,459 NR Yes
Final Report Update 1 Subgroups STUDY: FUNDING: RESEARCH OBJECTIVE: DESIGN: INTERVENTION: Dose: Duration: Sample size: INCLUSION: EXCLUSION: OTHER MEDICATIONS/ INTERVENTIONS ALLOWED: Alzheimer's Drugs
